Any therapeutic substance obtained from human blood, including whole blood and other blood components for transfusion, as well as plasma-derived pharmaceutical compounds, is referred to as a blood product. Medicinal (medical therapeutic) products obtained from human blood and plasma donations play an important role in medical care. Every year, blood products that are safe, effective, and of high-quality help to improve and save millions of lives. Inadequate or unsafe blood supplies have a detrimental influence on the ability of critical health services and programmes to offer proper patient care in a variety of acute and chronic illnesses. Access to safe, effective, and quality-assured blood products for all patients who require transfusion is a critical component of a functional health system and essential for patient safety.
Title : Cellular mechanisms involved in seronegative hemolysis
Donald R Branch, University of Toronto, Canada
Title : Immuno-Oncology (IO): 2023 and beyond
Stefan Gluck, Global Medical Affairs at Celgene Corporation, United States
Title : Managing bacterial eradication in disease and survival for life support systems on earth and space
A C Matin, Stanford Medical School, United States
Title : Hereditary hemolytic anemias due to red blood cell membranopathies rheological and genetic approach
Joan LLuis Vives Corrons, University of Barcelona, Spain
Title : The complete evidence that starling’s law responsible for many errors and misconceptions on fluid therapy in shock is wrong: The correct replacement is the hydrodynamic phenomenon of the porous orifice (G) tube
Ahmed N Ghanem, Mansoura University, Egypt
Title : Breaking Down Mental Health Stigmas
Thad Cummings, Thad Cummings, United States